Cardiac surgery has gone from opening chests and transplants to discreet repairs and replacement through a keyhole, dramatically changing recovery rates and trauma insurance along its decades-long journey.
Insurance for the medicines and biotech sector is growing increasingly complex and dynamic, and brokers need to consider every conceivable risk — to companies, consumers and even lab animals.
With chronic disease and injury increasingly endemic, so is underinsurance.
The sheer scale of our leading mental health problem has made declined insurance applications increasingly rare.
insurers and brokers need to keep up with changing the nature of trauma and TPD
Failure of medical devices can have far-reaching effects that make adequate insurance essential.
How do policies respond to product recalls, factory fires, broken equipment or class actions?
When management liability really comes into its own.
A flexible approach to work and study is a winning strategy for broker Gemma Gould.
Key figures from motor fleet insurance share their views on the big issues currently affecting the sector
Australia’s largest insurance broker cluster group, Steadfast, is proposing a public float. What will it mean to the shareholder
members of the currently unlisted private company? We speak to Chairman and CEO Robert Kelly.
Designed by eroomcreative | Engineered for success by EmpireOne
Follow us on: